Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea · Delayed Price · Currency is KRW

9,590.00

-30.00 (-0.31%)

Apr 24, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical	210.25B	219.70B	196.35B	179.68B	134.25B
Pharmaceutical Growth	-4.30%	11.89%	9.28%	33.84%	9.14%
Total	210.25B	219.70B	196.35B	179.68B	134.25B
Total Growth	-4.30%	11.89%	9.28%	33.84%	9.14%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	209.59B	217.52B	194.93B	178.83B	133.73B
South Korea Growth	-3.65%	11.59%	9.00%	33.72%	10.28%
Export	665.37M	2.18B	1.42B	842.66M	514.49M
Export Growth	-69.46%	53.48%	68.47%	63.78%	-70.33%
Total	210.25B	219.70B	196.35B	179.68B	134.25B
Total Growth	-4.30%	11.89%	9.28%	33.84%	9.14%

Source: S&P Global Market Intelligence.